You have 9 free searches left this month | for more free features.

Untreated nBCC

Showing 1 - 25 of 2,547

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)

Recruiting
  • Basal Cell Carcinoma
  • Basal Cell Nevus Syndrome
  • ASN-002
  • Brisbane, Queensland, Australia
  • +5 more
Feb 10, 2022

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

Not yet recruiting
  • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
  • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
  • (no location specified)
Sep 24, 2023

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Transverse Maxillary Deficiency Trial in Cairo (Hybrid Hyrax)

Active, not recruiting
  • Transverse Maxillary Deficiency
  • Hybrid Hyrax
  • Cairo, Giza, Egypt
    faculty of dentistry, Cairo university
Nov 8, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • (no location specified)
Aug 11, 2023

Transverse Maxillary Deficiency Trial in Cairo (Hybrid hyrax)

Active, not recruiting
  • Transverse Maxillary Deficiency
  • Hybrid hyrax
  • Cairo, Giza, Egypt
    Faculty of Dentistry, Cairo university
Aug 30, 2023

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Parkinson Disease Trial (CVN424 150 mg, Placebo)

Not yet recruiting
  • Parkinson Disease
  • CVN424 150 mg
  • Placebo
  • (no location specified)
Aug 25, 2023

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

Not yet recruiting
  • Follicular Lymphoma Stage II
  • +2 more
  • Ballarat, Victoria, Australia
  • +4 more
Mar 15, 2023

Follicular Lymphoma Trial in Italy (Radiotherapy, Radiotherapy plus Obinotuzumab)

Not yet recruiting
  • Follicular Lymphoma
  • Radiotherapy
  • Radiotherapy plus Obinotuzumab
  • Alessandria, Italy
  • +47 more
Jun 26, 2023

Hemodynamics in People With Untreated Preeclampsia Using

Not yet recruiting
  • Preeclampsia
  • Transthoracic Echocardiography
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 23, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Postmenopausal Symptoms, Hot Flashes Trial in Kalmar, Linköping (Strength training, High-intensity aerobic training)

Not yet recruiting
  • Postmenopausal Symptoms
  • Hot Flashes
  • Strength training
  • High-intensity aerobic training
  • Kalmar, Sweden
  • +1 more
Sep 8, 2023

Hypertension, Behavior and Behavior Mechanisms Trial (Written persuasive leaflet, Standard referral leaflet)

Not yet recruiting
  • Hypertension
  • Behavior and Behavior Mechanisms
  • Written persuasive leaflet
  • Standard referral leaflet
  • (no location specified)
Jul 20, 2023

Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)

Recruiting
  • Neovascular Age-Related Macular Degeneration
  • Brolucizumab 6mg
  • Aflibercept 2 mg
  • Guangzhou, Guangdong, China
  • +30 more
Jan 20, 2023

Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Pancreatic Adenocarcinoma Metastatic
  • Scottsdale, Arizona
    Clinical Trials Nurse Navigator
Oct 3, 2023

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Completed
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
  • +1 more
Dec 5, 2022

Schizophrenia, First Episode Psychosis Trial in Glen Oaks, Queens (search engine advertisement campaign)

Active, not recruiting
  • Schizophrenia
  • First Episode Psychosis
  • search engine advertisement campaign
  • Glen Oaks, New York
  • +1 more
Sep 27, 2022

Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • R-CHOP + acalabrutinib
  • Southampton, Hampshire, United Kingdom
  • +6 more
Oct 26, 2022

Pompe Disease Trial in New York, Fairfax (biological, drug, other)

Not yet recruiting
  • Pompe Disease
  • Cipaglucosidase alfa
  • +3 more
  • New York, New York
  • +1 more
Nov 2, 2023